CountryOfPapers CountryOfPapers
Journal list Promote Sponsor
verified SJR 2,291 · Q1 • database Scopus / SJR & Web of Science & DOAJ indexed
ImmunoTargets and Therapy
New Zealand · Dove Medical Press Ltd.
workspace_premium Q1 — Immunology visibility_off Single blind Peer Review lock_open Open Access · DOAJ

ImmunoTargets and Therapy

ImmunoTargets and Therapy is a journal indexed in SJR in Immunology and Immunology and Allergy with an H index of 29. It is an CC BY-NC Journal with a Single blind Peer Review review system, and It has a price of 1602 €. The scope of the journal is focused on immunology, immune system, immune-based therapy. It has an SJR impact factor of 2,291 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 2,291.

Publisher: Dove Medical Press Ltd.
Category: Immunology
Indexation: verifiedScopus / SJR verifiedWeb of Science verifiedDOAJ
open_in_new Portal NPD menu_book Author guidelines
schedule CountryOfPapers database fields
SJR Impact Factor trending_up
2,291 Q1
H-index 29
Acceptance rate pie_chart
57%
Source Acceptance_Rate
Time to publication hourglass_top
16 weeks
Field Average_time_publication_weeks
Publication cost (APC) payments
1.602 € Open Access
Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science DOAJ

SJR Impact

2,291

H-index

29

Docs (year)

56

Docs 3y

50

Total refs

3605

Cites 3y

369

Citable 3y

49

Cites/Doc 2y

4.55

Ref/Doc

64.38

Immediate OA

1602 €

Embargoed OA

NPD

Non OA / Submission

- €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

FAQs

What is the SJR of ImmunoTargets and Therapy?

ImmunoTargets and Therapy has an SJR of 2,291 (best quartile Q1) in the CountryOfPapers database.

What is the APC / publication cost?

Immediate OA APC is 1602 EUR.

What is the acceptance rate?

The acceptance rate recorded for ImmunoTargets and Therapy is 57%.